Parkville, Australia

Livesey Olerile

USPTO Granted Patents = 2 


 

Average Co-Inventor Count = 5.0

ph-index = 1

Forward Citations = 2(Granted Patents)


Company Filing History:


Years Active: 2021-2025

Loading Chart...
Loading Chart...
Loading Chart...
2 patents (USPTO):Explore Patents

Title: Livesey Olerile: Innovator in Drug Delivery Systems

Introduction

Livesey Olerile is a notable inventor based in Parkville, Australia. He has made significant contributions to the field of drug delivery, particularly in the formulation of inhalable biologically active agents. With a total of 2 patents to his name, Olerile's work is paving the way for advancements in medical treatments.

Latest Patents

Olerile's latest patents focus on a method and formulation for inhalation. This invention relates to drug delivery and emphasizes the delivery of biologically active agents in the form of dry powders for inhalation. The invention also encompasses methods for preparing such dry powder formulations and their subsequent use. This innovative approach has the potential to enhance the efficacy of drug delivery systems.

Career Highlights

Livesey Olerile is affiliated with the Beijing University of Technology, where he continues to engage in research and development in the field of drug delivery. His work is characterized by a commitment to improving health outcomes through innovative solutions.

Collaborations

Olerile has collaborated with esteemed colleagues such as Michelle McIntosh and David Morton. These partnerships have fostered a collaborative environment that encourages the exchange of ideas and expertise in the realm of drug delivery.

Conclusion

Livesey Olerile's contributions to the field of drug delivery through his innovative patents and collaborations highlight his role as a key figure in advancing medical technology. His work continues to inspire future developments in the industry.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…